Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency

Annals of Saudi Medicine

Volumn 23, Issue 6, 2003, Pages 354-357

  Naserullah, Zaki ^a,b,c   Alshammari, Ali ^a,b   Al Abbas, Marriam ^a,b   Abu Khamsseen, Yousef ^a,b   Qadri, Mohamed ^a,b   Al Jafer, Souad ^a,b   Al Wabel, Manal ^a,b  

^a QATIF CENTRAL HOSPITAL   (Saudi Arabia)

^b Maternity and Children Hospital   (Saudi Arabia)

^c NONE   (Saudi Arabia)

Author keywords

Alpha thalassemia; Deficiency; G6PD; Saudi Arabia; Sickle cell disease; Sickle cell trait

Indexed keywords

AGAR; ALKALI; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN;

AGAR GEL ELECTROPHORESIS; ALPHA THALASSEMIA; ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; EDUCATION; FEMALE; FLUORESCENCE ANALYSIS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBINOPATHY; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; PARAMEDICAL PERSONNEL; PRIORITY JOURNAL; SAUDI ARABIA; SICKLE CELL ANEMIA; SICKLE CELL TRAIT;

EID: 0346270723     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2003.354     Document Type: Article

References (30)

1. World Health Organization. Primary health care approaches for the prevention and control of congenital and genetic disorders: Report of WHO meeting. Cairo, Egypt. 6-8 December 1999. Geneva. 2000 (Document no. WHO/HGN/WG/00.1)
2. Nasserullah Z, Al Jame A, Abu Srair H, et al. Neonatal screening for sickle cell disease, glucose-6-phosphate dehydrogenises deficiency and alpha thalassemia in Qatif and Al Ahsa. Ann Saudi Med. 1998; 18(4):289-292.
3. El Hazmi M. Hemoglobinopathies, thalassemia and enzymopathies in Saudi Arabia. Saudi Med J. 192; 13:488-489.
4. Pearson H. A neonatal program for sickle cell anemia. Adv Pediatric. 1986;33:381-400.
5. Abu-Osba Y, Mallouh A. A comprehensive screening program in the newborn infant. 6th Annual Saudi Medical meeting. Jeddah; March 1981.
6. Al Awamy B, Almouzan M, Al Turkei M et al. Newborn screening for sickle cell hemoglobinopathies and other inherited erythrocyte disorders in eastern province of Saudi Arabia. Saudi Med J. 1986;7:P502-504.
7. Al Awamy B, Almouzan M, Niazi G, et al. Sickle cell anemia in early childhood in eastern province of Saudi Arabia. King Abdulaziz City Science and Technology publication; 1991:49.
8. Gaston MH, Joel V, Gerald W, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. Pediatrics. 1989;83:853.
9. Grover R. Program effects on decreasing morbidity and mortality. Pediatrics. 1989;83:819-822.
10. Whether D, Pearson H, Gaston M . Newborn screening for sickle cell disease and hemoglobinopathies. Pediatrics. 1989;83:813-814.
11. Vichinsky E, Hurst D, Earles A, et al. Newborn screening for sickle cell disease, effect on mortality. Pediatrics. 1988;81:749-755.
12. Cunningham G, Lorey F, Kling S, et al. Mortality among children with sickle cell disease identified by newborn screening durin g1990-1994 in California, Illinois and New Yok. MMWR Morbital WKLY REP. 1998;47:169-72.
13. Harris Ms, Eckman JR. Georgia's experience with newborn screening:1981 to 1985. Pediatrics. 1989;83:858-860.
14. Gaston MH, Vert JI, Woods G, et al. Prophylaxis with penicillin in children with sickle cell anemia. NEJ. 1986;314:1593-1599.
15. Rowley Pt. Parental receptivity to sickle cell trait identification. Pediatrics. 1989;83:891-893.
16. Wasi P. Population screening. In: Weatherall DJ, ed. Methods in hematology: The thalassemias. Edinburgh: Churchill living stone; 1983:134-144.
17. Weatheral DJ. The diagnostic features of different forms of thalassemia. In: Weatherall DJ, ed. Methods in hematology: The Thalassemias. Edinburgh: Churchill living stone; 1983:1-26.
18. Quadri MI, Islam S, Nasserullah Z. Hemoglobin H disease in eastern region of Saudi Arabia. Saudi Med J.2000;21:666-671.
19. Scoff RB. Survey of comprehensive centers for sickle cell disease. Pediatrics. 1989;83:908-909.
20. Akbar M, Al-Hilli F, Mandarin K, et al. Hemoglobinopathies and glucose-6-phosphate dehydrogenize deficiency in hospital birth in Bahrain. Ann Saudi Med. 1992; 12(4):536-539.
21. Panepito JA, Magid D, Rewers MJ, et al. Universal versus targeted screening for infant for sickle cell disease: Ascot-effectiveness analysis. J Pediatr. 2000;201-207.
22. Consensus development panel. National Institute of Health. Newborn screening for SCD and other hemoglobinopathies. JAMA. 1987;258:1205-1209.
23. Qatif primary health care administration. Projected population of Qatif sector. Saudi Arabia;2000.
24. Cao A, Rosateli MC, Galanello R. control of beta-thalassemia by carrier screening, genetic counseling and parental diagnosis: The Sardinian experience. Ciba Found Symp. 1976;197:137-155.
25. Angastiniotis M, Kryiakidou S, Hadjiminas M. How thalassemia was controlled in Cyprus. World Health Forum. 1986;7:291-297.
26. Loukopoulos D. Current Status of thalassemia and sickle syndromes in Greece. Semin Hematol. 1996;33:76-86.
27. Ahmed S, Saleem M, Modell B, et al. Screening extended families for genetic hemoglobin disorders in Pakistan. New Eng J Med. 2002;347(15):1162-1168.
28. Hernandez S. Social work prospective. Pediatrics. 1989;83: 903-905.
29. Earles A. Nursing prospective. Pediatrics. 1989;83:901-902.
30. Hertez S. Social work prospective. Pediatrics. 1989;83:903-905.